Literature DB >> 24706848

Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis.

Hemant P Joshi1, Indira V Subramanian, Erica K Schnettler, Goutam Ghosh, Rajesha Rupaimoole, Colleen Evans, Manju Saluja, Yawu Jing, Ivan Cristina, Sabita Roy, Yan Zeng, Vijay H Shah, Anil K Sood, Sundaram Ramakrishnan.   

Abstract

Hypoxia-driven changes in the tumor microenvironment facilitate cancer metastasis. In the present study, we investigated the regulatory cross talk between endocytic pathway, hypoxia, and tumor metastasis. Dynamin 2 (DNM2), a GTPase, is a critical mediator of endocytosis. Hypoxia decreased the levels of DNM2. DNM2 promoter has multiple hypoxia-inducible factor (HIF)-binding sites and genetic deletion of them relieved hypoxia-induced transcriptional suppression. Interestingly, DNM2 reciprocally regulated HIF. Inhibition of DNM2 GTPase activity and dominant-negative mutant of DNM2 showed a functional role for DNM2 in regulating HIF. Furthermore, the opposite strand of DNM2 gene encodes miR-199a, which is similarly reduced in cancer cells under hypoxia. miR-199a targets the 3'-UTR of HIF-1α and HIF-2α. Decreased miR-199a expression in hypoxia increased HIF levels. Exogenous expression of miR-199a decreased HIF, cell migration, and metastasis of ovarian cancer cells. miR-199a-mediated changes in HIF levels affected expression of the matrix-remodeling enzyme, lysyloxidase (LOX). LOX levels negatively correlated with progression-free survival in ovarian cancer patients. These results demonstrate a regulatory relationship between DNM2, miR-199a, and HIF, with implications in cancer metastasis.

Entities:  

Keywords:  iron regulation; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24706848      PMCID: PMC3986124          DOI: 10.1073/pnas.1317242111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.

Authors:  Qin Yan; Steven Bartz; Mao Mao; Lianjie Li; William G Kaelin
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

2.  Hypoxamirs and mitochondrial metabolism.

Authors:  Katherine A Cottrill; Stephen Y Chan; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

3.  Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.

Authors:  Kwan-Sik Kim; Saubhik Sengupta; Michael Berk; Yong-Geun Kwak; Pedro F Escobar; Jerome Belinson; Samuel C Mok; Yan Xu
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

4.  Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development.

Authors:  Donghoon Yoon; Yves D Pastore; Vladimir Divoky; Enli Liu; Agnieszka E Mlodnicka; Karin Rainey; Premysl Ponka; Gregg L Semenza; Armin Schumacher; Josef T Prchal
Journal:  J Biol Chem       Date:  2006-06-19       Impact factor: 5.157

5.  Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.

Authors:  Nathalie M Mazure; Caroline Chauvet; Brigitte Bois-Joyeux; Marguerite-Anne Bernard; Habib Nacer-Chérif; Jean-Louis Danan
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

6.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

7.  Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.

Authors:  R Chen; A B Alvero; D A Silasi; M G Kelly; S Fest; I Visintin; A Leiser; P E Schwartz; T Rutherford; G Mor
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

Review 8.  Derailed endocytosis: an emerging feature of cancer.

Authors:  Yaron Mosesson; Gordon B Mills; Yosef Yarden
Journal:  Nat Rev Cancer       Date:  2008-11       Impact factor: 60.716

9.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Reto A Schuepbach; Erinn Rankin; Sophie Vaulont; Volker H Haase; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

10.  Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster.

Authors:  Ayumu Taguchi; Kiyoshi Yanagisawa; Masaharu Tanaka; Ke Cao; Yasushi Matsuyama; Hidemi Goto; Takashi Takahashi
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

View more
  30 in total

1.  The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy.

Authors:  Xin Chen; Yun-Qian Gao; Yan-Yan Zheng; Wei Wang; Pei Wang; Juan Liang; Wei Zhao; Tao Tao; Jie Sun; Lisha Wei; Yeqiong Li; Yuwei Zhou; Zhenji Gan; Xuena Zhang; Hua-Qun Chen; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

Review 3.  Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

Review 4.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

5.  Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration.

Authors:  Ruisi Wang; Qian Ding; Thiago M De Assuncao; Taofic Mounajjed; Jessica L Maiers; Changwei Dou; Sheng Cao; Usman Yaqoob; Robert C Huebert; Vijay H Shah
Journal:  Am J Pathol       Date:  2016-11-10       Impact factor: 4.307

6.  miR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcome.

Authors:  Jacqueline Keßler; Swetlana Rot; Matthias Bache; Matthias Kappler; Peter Würl; Dirk Vordermark; Helge Taubert; Thomas Greither
Journal:  Oncol Lett       Date:  2016-10-26       Impact factor: 2.967

Review 7.  miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.

Authors:  Rajesha Rupaimoole; George A Calin; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Discov       Date:  2016-02-10       Impact factor: 39.397

Review 8.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

9.  The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.

Authors:  Mariyam Zuberi; Imran Khan; Gauri Gandhi; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-03-07

Review 10.  A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target.

Authors:  Delphine Trochet; Marc Bitoun
Journal:  J Exp Clin Cancer Res       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.